Skip to main content
Journal cover image

SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS

Publication ,  Conference
Lawitz, E; Rodriguez-Torres, M; Rustgi, VK; Hassanein, T; Rahimy, MH; Crowley, CA; Freddo, JL; Muir, AJ; McHutchison, JG
Published in: HEPATOLOGY
October 1, 2010

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

334A / 335A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lawitz, E., Rodriguez-Torres, M., Rustgi, V. K., Hassanein, T., Rahimy, M. H., Crowley, C. A., … McHutchison, J. G. (2010). SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS. In HEPATOLOGY (Vol. 52, pp. 334A-335A). Boston, MA: WILEY-BLACKWELL.
Lawitz, Eric, Maribel Rodriguez-Torres, Vinod K. Rustgi, Tarek Hassanein, Mohamad H. Rahimy, Constance A. Crowley, James L. Freddo, Andrew J. Muir, and John G. McHutchison. “SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS.” In HEPATOLOGY, 52:334A-335A. WILEY-BLACKWELL, 2010.
Lawitz E, Rodriguez-Torres M, Rustgi VK, Hassanein T, Rahimy MH, Crowley CA, et al. SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 334A-335A.
Lawitz E, Rodriguez-Torres M, Rustgi VK, Hassanein T, Rahimy MH, Crowley CA, Freddo JL, Muir AJ, McHutchison JG. SAFETY AND ANTIVIRAL ACTIVITY OF ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE-1 CHRONIC HCV PATIENTS. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 334A-335A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

334A / 335A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics